Assavapokee N, et al. J Gynecol Oncol. 2025 Mar;36:e96. https://doi.org/10.3802/jgo.2025.36.e96

Background: Sexual satisfaction is vital for the sexual health and well-being of both cervical cancer patients and their spouses. Sexual dissatisfaction can arise from negative treatment, making it important to examine the factors that influence sexual satisfaction. Objective: The purpose of this study was to explore the factors affecting the sexual satisfaction of Thai women with cervical cancer after complete treatment and their spouses. Materials and Methods: A predictive correlational study was conducted with 100 couples using convenience sampling. The study was based on the ecological theory framework. Data were collected from April 2023 to January 2024 in two tertiary hospitals through five questionnaires: a demographic questionnaire, the Thai Hospital Anxiety and Depression Scale, the Charlson Comorbidity Index, the Couple Relationship Scale, Natsal 2000, and the New Sexual Satisfaction Scale. Data analysis was performed using multiple linear regression. Results: The multiple regression analysis showed that sexual difficulties and duration of marriage predicted 25.6% of the variance in sexual satisfaction among women with cervical cancer. The duration of marriage (b = −0.48, p = 0.012) had a stronger impact than sexual difficulties (b = −2.82, p = 0.005). Sexual difficulties and couple relationships accounted for 34.9% of the variance in sexual satisfaction for spouses. Sexual difficulties (b = −3.13, p = 0.004) had a greater effect than couple relationships (b = 0.30, p = 0.003). Conclusions: Healthcare providers should promote constructive communication between couples through open, respectful, and supportive dialogue to strengthen their relationship, improve mutual understanding, address sexual difficulties, and enhance sexual satisfaction for women with cervical cancer after treatment and their spouses. The findings results can inform future intervention research aimed at improving sexual satisfaction in this population one-year post treatment.

Lertkhachonsuk AA, et al. J Gynecol Oncol. 2022 Jan;33:e36. https://doi.org/10.3802/jgo.2022.33.e36